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Abstract  
Background: Physiological changes in maternal thyroid function during pregnancy 
necessitate the use of pregnancy specific reference ranges. Dynamic changes in TSH within 
the first trimester of pregnancy have been reported, but more evidence is needed to 
substantiate the findings. The objective of this study was to estimate pregnancy week-
specific reference ranges for maternal TSH and free T4 (fT4) in early pregnancy. 
Methods: We consecutively recruited serum residues from blood samples collected as part 
of the prenatal screening in the North Denmark Region, 2011-2015. TSH, fT4, thyroid 
peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (Tg-Ab) were measured using 
an ADVIA Centaur XPT immunoassay. The reference cohort included 10,337 pregnant 
women who had no thyroid disease or other autoimmune diseases and were TPO-Ab and 
Tg-Ab negative. The main outcome measures were lower and upper reference limits (2.5 
and 97.5 percentiles) for TSH and fT4 stratified by week of pregnancy.  
Results: Blood samples were drawn in pregnancy week 4-20 (median week 10), and 92% of 
the pregnancies ended with live birth. TSH varied considerably in the first trimester of 
pregnancy, and the levels were highest in early pregnancy (week 4-6: 0.6-3.7 mIU/l) 
followed by a gradual decline to lower levels in week 9-11 (0.1-2.8 mIU/l) and 12-14 (0.03-
2.8 mIU/l). Maternal fT4 showed less variation (week 4-6: 12-20 pmol/l; week 9-11: 13-21 
pmol/l; week 12-14: 13-20 pmol/l). 
Conclusions: The results corroborate dynamic week-specific changes in maternal TSH in 
early pregnancy. The use of uniform lower and upper reference range for TSH in early 
pregnancy may be too simple.  
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Introduction 
Thyroid function in pregnant women is of clinical relevance (1). Thyroid hormones in the 
fetus are solely of maternal origin in early pregnancy, and the crucial role of thyroid 
hormones in fetal development emphasizes the importance of adequate maternal thyroid 
hormone levels (2). The physiological changes in maternal thyroid function in early 
pregnancy are mediated via estrogen, human chorionic gonadotropin (hCG) and 
alterations in the metabolism of thyroid hormones, and these changes necessitate the use 
of pregnancy specific reference ranges for evaluation of maternal thyroid function (3). 
Much emphasis has been on the use of trimester specific reference ranges (1), but recent 
data indicate that the physiological changes in maternal TSH in early pregnancy are 
marked, even within the first trimester of pregnancy, and that the use of a uniform 
reference range may be too simple (4,5).  
Thyroid dysfunction in women of reproductive age is predominantly of autoimmune 
origin (6,7). Thyroid peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (Tg-Ab) 
are associated with the presence of hypothyroidism, and TSH is higher in individuals who 
are positive for thyroid autoantibodies (8). Thus, it is recommended to exclude individuals 
with TPO-Ab from a reference cohort (1). We previously described the week-specific 
changes in maternal TSH and free T4 (fT4) in a large cohort of pregnant women from the 
Danish National Birth Cohort established in 1997-2003 (5). Pregnant women with known 
thyroid disease were excluded, but the measurement of thyroid autoantibodies was not 
possible in this cohort. Furthermore, mandatory iodine fortification of salt was introduced 
in Denmark in the year 2000 (9), and data on the level of TSH in Danish pregnant women 
after iodine fortification are warranted.  
The present study aimed to evaluate the week-specific reference ranges for TSH and fT4 
in a recent, large cohort of pregnant women from the North Denmark Region established 
in 2011-2015. Blood samples were consecutively collected as part of the prenatal 
screening for chromosomal anomalies in early pregnancy and used for the measurement 
of maternal thyroid function (TSH and fT4) and thyroid autoantibodies (TPO-Ab and Tg-
Ab). 
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Materials and Methods 
Study population  
Nationwide prenatal screening for fetal chromosomal anomalies was implemented in 
Denmark in 2004 (10). It includes the measurement of biochemical markers in a blood 
sample from the pregnant woman drawn at the first pregnancy visit in general practice. All 
serum samples from pregnant women in the North Denmark Region are analyzed at the 
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark. 
Serum residues from all samples received in the laboratory from June 28, 2011 to January 
5, 2015 were collected for the present study and stored at minus 80° Celsius until the 
measurement of maternal thyroid function and thyroid autoantibodies. Serum residues 
from January to March 2012 and January to March 2013 were not available due to logistics 
in the laboratory, and a total of 18,186 samples were included in the study (Figure 1). The 
study was approved by the North Denmark Region Committee on Health Research Ethics 
(N-20150015) and the Danish Data Protection Agency (J.nr. 2008-58-0028). 
 
Laboratory procedures 
Serum TSH, fT4, TPO-Ab and Tg-Ab were measured from September 2015 to May 2016 in 
the Department of Clinical Biochemistry, North Denmark Regional Hospital, Hjørring, 
Denmark, using an ADVIA Centaur XPT automatic immunoassay (Siemens Healthineers, 
Germany). For TSH (TSH3-Ultra), the functional sensitivity provided by the manufacturer 
was 0.008 mIU/l and the analytical measurement range was 0.008-150 mIU/l. Intermediate 
precision was 3.6-5.2% for six patient serum samples in the range from 1.0-132.8 mIU/l. 
The reference range for non-pregnant adults was 0.55-4.78 mIU/l. For free T4, the 
analytical measurement range was 1.3-155 pmol/l, and intermediate precision was 3.4-
4.6% for three concentrations in the range from 9.3-38.8 pmol/l. The reference range for 
non-pregnant adults was 11.5-22.7 pmol/l. For TPO-Ab, the analytical measurement range 
was 28-1300 U/mL, and intermediate precision was 7.6 and 3.1% for concentrations of 71 
and 459 U/ml, respectively. For Tg-Ab, the analytical measurement range was 15-500 
U/mL, and intermediate precision 3.9-6.6% for three concentrations in the range from 71-
344 U/ml. A cut-off value of 60 U/ml was given by the manufacturer for both TPO-Ab and 
Tg-Ab, and women with measurements above this cut-off were considered thyroid 
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autoantibody positive in the present study. The cut-off for TPO-Ab in pregnant women has 
previously been evaluated for the ADVIA Centaur assay and was at a comparable level (54 
U/ml) (11). We included a sub-analysis in which the cut-off was halved to 30 U/ml to 
evaluate a possible impact of subtle thyroid autoimmunity.  
 
Data linkage 
The date of blood sampling and results of thyroid function parameters and thyroid 
autoantibodies were linked to information in Danish nationwide registers via Statistics 
Denmark. All citizens in Denmark are provided a unique personal identification number, 
which is used in all registers and enables data linkage (12). Data were available in Statistics 
Denmark in encrypted form so that no individuals could be identified by the researcher. 
First, pregnancy outcome and the week of blood sampling during pregnancy were 
established via linkage to the Medical Birth Register (MBR) (13) and the Danish National 
Hospital Register (DNHR) (14). The MBR holds information on all live- and stillbirths in 
Denmark including information on whether it was a singleton or multiple birth, and on 
maternal age, parity, origin (country of birth), smoking in pregnancy, and pre-pregnancy 
body mass index (BMI). The DNHR holds information on all in- and outpatient visits to 
Danish hospitals with a diagnosis of pregnancy loss including induced abortion, 
spontaneous abortion, molar and ectopic pregnancy coded according to the 10th 
International Classification of Disease (ICD-10). In both registers, information on date and 
gestational age at the time of pregnancy termination is available, and this information was 
linked to the date of blood sampling in early pregnancy and used to establish the 
pregnancy week of blood sampling. Gestational age is established by ultrasound in 
Denmark (15) and registered in full weeks plus days counted from the first day of the last 
menstrual period e.g. 8+2, which corresponds to the 9th week of pregnancy. Information 
on maternal diseases before, during and after the pregnancy was obtained from 1) 
hospital diagnosis of disease registered from January 1, 1994 to December 31, 2016 in the 
DNHR and coded according to ICD-10 and from 2) redeemed prescriptions of drugs 
registered from January 1, 1995 to December 31, 2016 in the Danish National Prescription 
Register (DNPR) (16) and coded according to the Anatomical Therapeutic Chemical (ATC) 
Classification System.  
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Reference cohort 
Among the 18,186 blood samples collected in early pregnancy and used for measurement 
of maternal thyroid function and thyroid autoantibodies, altogether 17,681 were linked in 
Statistics Denmark with information on outcome of the pregnancy and gestational age 
(Figure 1). Some women had more than one blood sample drawn during a pregnancy or 
consecutive pregnancies in the study period and the first blood sample during the first 
pregnancy in the study period was selected for each woman (Figure 1). Multiple 
pregnancies were excluded from the reference cohort as were women with a registration 
of thyroid or other autoimmune diseases (diabetes, rheumatoid arthritis, and 
inflammatory bowel disease) before, during or after the pregnancy, women with a 
registration of thyroid interfering medication (antiepileptic drugs, dopamine agonists, 
lithium, and prednisolone) in pregnancy defined by redeemed prescriptions in the one-
year period prior to pregnancy termination, and women who were positive for TPO-Ab 
and/or Tg-Ab, leaving 10,337 pregnant women in the reference cohort (Figure 1).  
 
Statistical analyses 
Pregnancy week-specific results of TSH and fT4 analyses are reported as median, 2.5 
percentile and 97.5 percentile with 95% confidence interval. The early (week 4-6) and the 
late (week 15-20) pregnancy weeks were collapsed to obtain a sufficient number of 
individuals in the groups. Within each pregnancy week group, Box-Cox transformation was 
used to obtain normal distribution prior to the exclusion of outliers using Tukey’s fences 
(17). Analyses were performed both in the full reference cohort (n=10,337) and among 
women who ended the pregnancy with the birth of a live-born child (n=9515). Predictors 
of maternal TSH and fT4 were evaluated in pregnancy weeks 9-11, which included the 
largest number of individuals. This evaluation was performed among women who ended 
the pregnancy with the birth of a live-born child and had available information on 
maternal characteristics (n=7438). All predictors (maternal age, parity, origin, smoking and 
BMI) were assessed as independent categorical variables in multivariate linear regression 
with Box-Cox transformed TSH or free T4 as dependent variable, and significant predictors 
were selected for univariate stratified analyses. Statistical analyses were performed using 
STATA version 15 (Stata Corp).  
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Results 
Reference cohort 
Altogether 10,337 pregnant women were included in the reference cohort (Figure 1). 
Maternal age was at a median of 29 years (range 16-51 years), and 88% of the women 
were born in Denmark. The blood sample had been drawn in median pregnancy week 10 
(9+0 to 9+6) ranging from the 4th week (3+0 to 3+6) to the 20th week (19+0 to 19+6). The 
birth of a live-born child was the most frequent outcome of pregnancy (n=9515), whereas 
induced abortion (n=140), spontaneous abortion (n=639), molar and ectopic pregnancy 
(n=12), and still birth (n=31) accounted for a smaller proportion of the cohort.   
 
Reference ranges 
Week-specific median and upper and lower reference limits with 95% CI for TSH and fT4 
showed a similar trend when established within the full cohort of 10,337 pregnant women  
and among the 9515 women who ended the pregnancy with the birth of a live-born child 
(Figure 2 and Table 1). TSH showed considerable variation in the median and upper and 
lower reference limits during early pregnancy being high in the early pregnancy weeks 
followed by a gradual decline to low levels in pregnancy week 9-11 and in week 12-14, 
which was most pronounced for the lower reference limit. Maternal fT4 showed an 
opposite pattern, but less pronounced variation with the highest levels in pregnancy week 
9-11. A uniform reference range for TSH and fT4 in the first trimester of pregnancy (week 
4-12) was 0.14-2.9 mIU/l for TSH and 13.0-20.5 pmol/l for fT4 with similar figures within 
the full cohort and within the cohort of women with live births. However, the week-
specific changes during the first trimester (Figure 2 and Table 1) indicated that shorter 
distinct intervals could be described (Table 2), particularly for TSH, with an initial high TSH 
period followed by subsequent lower TSH periods in week 9-11 and 12-14. When the cut-
off for TPO-Ab and Tg-Ab was halved to 30 U/ml, the study population was restricted to 
6216 pregnant women.  Reference limits for maternal thyroid function tests were similar 
with the same trend during the first trimester of pregnancy (week 4-8: TSH 0.29-3.2 mIU/L, 
fT4 12.4-19.3 pmol/l; week 9-11: TSH 0.13-2.8 mIU/L, fT4 12.8-20.2 pmol/l; week 12-14: 
TSH 0.04-2.8 mIU/L, fT4 12.7-19.5 pmol/l). Considering the exclusion of TPO- and/or Tg-Ab 
positive women, the TSH reference limits prior to exclusion were 0.43-3.8 mIU/L for week 
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4-8, 0.17-3.2 mIU/L for week 9-11 and 0.08-3.1 mIU/L for week 12-14. After exclusion of 
TPO-Ab positive women only, the TSH reference ranges were 0.40-3.4 mIU/L for week 4-8, 
0.14-2.9 mIU/L for week 9-11 and 0.03-2.8 mIU/L for week 12-14, and the same after 
exclusion of Tg-Ab positive women only (week 4-8: 0.40-3.5 mIU/L, week 9-11: 0.15-2.9 
mIU/L, week 12-14: 0.03-2.7 mIU/L). Reference limits for fT4 were similar to those 
presented in Table 2 irrespective of whether TPO- and/or Tg-Ab positive women were 
excluded (data not shown).  
 
Maternal characteristics 
Different maternal characteristics were assessed for women who ended the pregnancy 
with the birth of a live-born child (Table 3). In multivariate analyses, multiparity and 
smoking in pregnancy were significant predictors of lower maternal TSH, whereas higher 
maternal BMI associated with higher TSH. Maternal age and origin were not significant 
predictors of TSH.  For maternal fT4, higher maternal age, higher BMI and smoking in 
pregnancy were significant predictors of lower fT4, whereas multiparity and origin (not 
born in Denmark) associated with higher maternal fT4. However, when stratified reference 
limits for TSH and fT4 in pregnancy week 9-11 were calculated, the impact of individual 
predictors was modest and confidence limits were overlapping (Table 4). A disparity was 
most pronounced for maternal BMI, which showed higher TSH and lower fT4 limits in 
obese women with pre-pregnancy BMI ≥ 30 kg/m2. Reference limits among overweight 
women with BMI in the range from 25 to 29.9 kg/m2 (TSH 0.13-2.73 mIU/l, fT4: 13.1-20.6 
pmol/l) were comparable to the reference limits observed among women with BMI below 
25 kg/m2 (TSH 0.11-2.75 mIU/l, fT4: 13.2-20.6 pmol/l). 
 
Discussion 
Main findings 
The establishment of pregnancy week-specific reference ranges for maternal thyroid 
function parameters in a large cohort of thyroid autoantibody negative Danish pregnant 
women corroborate dynamics of TSH during the first trimester of pregnancy. The findings 
imply that the clinical assessment of smaller time intervals within the first trimester of 
pregnancy may be preferable to the use of a uniform reference range for evaluation of 
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maternal thyroid function. Reference limits for maternal fT4 showed opposite, but less 
marked dynamics during first trimester and a uniform reference range may apply. 
Maternal characteristics such as age, parity, origin, smoking, and BMI associated with 
maternal thyroid function parameters, but only small differences were observed in 
stratified reference limits for TSH and fT4. 
 
Reference ranges  
Valid reference ranges are an important part of diagnosis and management in clinical 
patient care, and as part of exposure and outcome definitions in clinical research. 
Comprehensive guidance exists on how to establish reference ranges (17), but still many 
aspects remain debatable on the selection of the reference cohort and it may further pose 
a challenge to obtain a sufficient number of samples. Whereas some laboratory tests are 
hardly affected by pregnancy, maternal thyroid function is considerably influenced by 
physiological changes in pregnancy, and non-pregnant reference ranges should not be 
used (3). Another challenge related to thyroid function parameters determined by 
automatic immunoassays is the potential disparity in results obtained with different 
methods. This is particularly a concern for the measurement of free thyroid hormones, 
because the determination of free thyroid hormone concentration by an automatic 
immunoassay is an indirect approach with no complete separation of free and protein-
bound hormone (18-20). Thus, clinical guidance recommends the use of method- and 
pregnancy specific reference ranges (1).  
The present study and previous investigations have questioned the use of a uniform 
reference range in the first trimester of pregnancy (4,5,21-25). We have now observed in 
two separate, large cohorts of Danish pregnant women that TSH reference limits are highly 
dynamic in the first trimester of pregnancy with an initially high TSH period followed by 
gradual decline in week 7-8 to lower levels in week 9 and onwards. The present study 
suggests that the lower TSH limit continues to be low in the beginning of second trimester, 
and is lower in week 12-14 compared with week 9-11, whereas no difference was 
observed in the upper limit between these periods of pregnancy. These findings are in 
keeping with the clinical experience that TSH may remain low at the beginning of the 
second trimester. We speculate whether this relates to a prolonged effect of hCG, and if 
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women with lower TSH levels are more sensitive to the effect of hCG. This also conforms 
to the more pronounced dynamics in the lower TSH reference limit within the first 
trimester observed in the present study and in our previous report (5). Uncertainty may 
prevail on the exact week of pregnancy in early pregnancy, and the use of pregnancy 
week-specific reference ranges may not be superior in clinical practice. However, our data 
suggest that clinical awareness at different time points in early pregnancy may be 
warranted for the classification of maternal thyroid function with a higher TSH in the time 
period up to pregnancy week 8 followed by a lower TSH during the period of week 9-11 
and by week 12-14.  
The mechanisms underlying the dynamic changes in TSH likely relate to the balance 
between the hCG effect in early pregnancy, which tends to suppress TSH, and the activity 
of the type 3 deiodinase (DIO3) in the placenta, which tends to increase TSH (3). DIO3 is 
expressed from the early weeks of pregnancy (26-29), whereas hCG peaks in pregnancy 
week 9-10 (30). Thus, the initial high TSH period may reflect that the DIO3 effect is 
predominant in the early pregnancy weeks and the later low TSH period may reflect a 
dominant hCG effect.  
A strength of the present study is the possibility to measure thyroid autoantibodies in a 
large cohort of pregnant women and to exclude women who were positive for TPO-Ab 
and/or Tg-Ab from the reference cohort. Such an approach was not possible in our 
previous investigation of Danish pregnant women (5), but it is noteworthy that similar 
dynamics of TSH levels in the first trimester were observed in the two Danish 
investigations. We used the cut-off value of 60 U/ml provided by the manufacturer to 
identify women with thyroid autoantibodies and 13% of the women were TPO-Ab and/or 
Tg-Ab positive. For comparison, the frequency was 16% when evaluated in a cohort of 
Danish pregnant women in East Denmark in 2007-2008 using the same cut-off level with a 
different immunoassay (31). The selection of reference individuals for the establishment of 
reference ranges is debatable, and a main focus regarding thyroid function analyses is on 
how to handle individuals with TPO- and/or Tg-Ab. In the present study, women with 
known or later diagnosed thyroid disease were excluded, as were outliers of TSH and fT4. 
We found slightly lower TSH reference limits following the subsequent exclusion of women 
hosting thyroid autoantibodies. Notably, the reference limits were consistent irrespective 
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of the cut-off used or whether TPO- and/or Tg-positive women were excluded. Adding to 
this, a recent study of pregnant women in a Swedish cohort showed that the additional 
exclusion of Tg-Ab positive women on top of TPO-Ab hardly changed the reference limits 
(32). More evidence is needed as part of the discussion on how to manage pregnant 
women who are positive for thyroid autoantibodies and who have no known thyroid 
disease.   
The clinical guidance from the America Thyroid Association on the management of 
thyroid disease in pregnant women recommends to reduce the upper reference limit with 
approximately 0.5 mIU/l in the first trimester of pregnancy if local method specific 
reference ranges are not available (1). We observed that the upper limit of TSH was below 
this limit throughout pregnancy in this study and in our previous investigation conducted 
around the time when iodine fortification was implemented in Denmark (5). The uniform 
upper limit of TSH in first trimester was 3.4 mIU/l in the study of pregnant women in East 
Denmark in 2008-2009 (33) and therefore slightly higher than the limit of 2.9 mIU/l 
observed in the present study conducted in West Demark. Methodological differences in 
thyroid function assays may play a role, but the discrepancy is also compatible with 
observations in the general Danish population of regional differences in TSH (34). 
Considering the clinical proposal of a uniform TSH reference limit in the first trimester of 
pregnancy (1), our results indicate that reference limits vary considerably within the first 
trimester of pregnancy and suggest that it may be feasible to establish TSH reference limits 
for shorter time periods during pregnancy.  
 
Predictors  
Hyperthyroidism and hypothyroidism in women of reproductive age is mainly of 
autoimmune origin (6,7). Autoimmune thyroid disease is considered multifactorial, and 
genetic as well as environmental risk factors have been described (35). For the 
establishment of reference ranges, it is often relevant to consider if patient characteristics 
influence the reference limits and whether stratified reference ranges are needed in 
clinical practice. We were able to evaluate the impact of different maternal characteristics 
on the reference limits for TSH and fT4 in early pregnancy. In line with our previous 
investigation of Danish pregnant women (5), we observed that many factors were 
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associated with TSH and fT4, but the impact of the individual factors in stratified reference 
limits was limited. These findings question the clinical usefulness of stratified reference 
ranges and may favor the use of the pregnancy week-specific reference combined with 
clinical awareness of maternal characteristics that may affect thyroid function results, 
particularly in the evaluation of patients with borderline results. Most pronounced was the 
effect of maternal BMI with higher TSH and lower fT4 limits in obese women, which is 
compatible with other reports (36-38). The role of other maternal characteristics has been 
less consistently reported in the literature (39), and our findings are less clear. We 
observed a trend towards lower TSH levels in multiparous women, which is in line with 
some studies, whereas others found no effect (39). In our study, ethnicity was not a 
predictor of maternal TSH. This contrasts with other reports (40,41). These studies had the 
possibility to stratify by sub-type of maternal ethnic background, whereas the register-
based design of our study only provided the possibility to investigate reference ranges 
according to information on whether the pregnant woman was born in or outside of 
Denmark. Considering maternal smoking, the effect was smaller, but the results suggested 
lower TSH and fT4 limits in smokers. Studies of the population in general have shown that 
smoking tends to be associated with lower TSH levels and an increase the peripheral 
thyroid hormone concentrations. possibly caused by increased activity in the sympathetic 
nervous system (42). Our previous Danish investigation (5) and other reports (43) similarly 
showed lower fT4 levels associated with smoking in pregnancy, whereas other studies 
found no difference (32). Further studies are needed to corroborate and extend these 
findings, and to evaluate the clinical impact on maternal and fetal outcomes.   
 
Methodological comments 
The present large cohort of pregnant women allowed for the stratification of reference 
ranges by the week of pregnancy with an appropriate number of individuals in each of the 
stratified groups. However, the number of samples in the early and late pregnancy weeks 
was limited and groups were collapsed to obtain sufficient sample size. We excluded 
women with autoimmune disease from the reference cohort via linkage to information in 
Danish nationwide registers, and we used a recommended method of outlier detection 
(17).  
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Serum samples for the present study were consecutively collected as part of prenatal 
screening in Denmark, and the rate of participation is high (10). This method of inclusion is 
expected to minimize the risk of selection bias, and the number of samples obtained was 
representative for the expected number of pregnant women in the North Denmark Region 
around the time of inclusion.  
Determination of pregnancy outcome was performed via linkage to Danish nationwide 
registers, and the validity is considered high (44). This provided the possibility to evaluate 
reference ranges in the full cohort and in pregnancies with live births. Notably, results are 
consistent in both cohorts, which may apply to the design of future studies and 
considerations on the selection of reference cohorts. Information was available on 
pregnancy loss and births including spontaneous and induced abortions as well as live and 
still births at hospital and at home. However, pregnancies terminating with spontaneous 
abortion without clinical recognition and hospital contact would not have been identified 
with an outcome of pregnancy. 
Information on a number of maternal characteristics were available for women who 
terminated the pregnancy with the birth of a live-born child. Pre-pregnancy BMI and 
smoking status were self-reported by the pregnant women, but any misclassification is 
expected to be non-differential regarding thyroid function.  
All samples were analyzed consecutively in the same laboratory after the last sample 
had been collected, and storage time until the present analyses ranged from two to six 
years. The storage time is not expected to influence our results since thyroid function 
parameters and thyroid autoantibodies in pregnant women have been shown to be stable 
for more than 20 years of storage at minus 25° Celsius (45).  
 
Conclusion 
Reference limits for maternal TSH are dynamic during the first trimester of pregnancy with 
an initial high TSH period followed by a gradual decline to a low TSH period. A clinical focus 
on shorter time intervals within the first trimester of pregnancy may be preferable. Future 
investigations should evaluate the dynamics in maternal thyroid function parameters in 
other populations using different thyroid function assays. It remains to be addressed 
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whether clinical awareness of the dynamic changes in maternal TSH in early pregnancy and 
of maternal characteristics will improve patient care and clinical research.  
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Table 1 Pregnancy week specific median and reference limits with 95% confidence intervals for maternal TSH and free T4 in all 
pregnant women from the North Denmark Region and in pregnant women who ended the pregnancy with live birth.  
 Maternal TSH (mIU/l) Maternal free T4 (pmol/l) 
Week na 2.5p 95% CIb 97.5p 95% CIc na 2.5p 95% CIb 97.5p 95% CIc
All     
4-6 171 0.62 0.27-0.66 3.65 3.16-
3.78 
172 12.4 12.2-
13.1 
20.0 19.2-
21.7 
7 251 0.46 0.36-0.59 3.20 2.95-
3.51 
255 12.3 11.9-
12.6 
19.9 19.2-
21.2 
8 739 0.28 0.22-0.36 3.21 3.00-
3.69 
737 12.7 12.4-
12.9 
19.9 19.6-
20.5 
9 2,670 0.15 0.12-0.17 2.94 2.83-
3.03 
2,649 13.1 13.0-
13.1 
20.6 20.3-
20.8 
10 3,404 0.12 0.10-0.14 2.72 2.65-
2.80 
3,456 13.1 12.9-
13.2 
20.6 20.4-
20.8 
11 1,694 0.13 0.10-0.14 2.88 2.74-
2.99 
1,710 12.9 12.8-
13.1 
20.3 20.0-
20.7 
12 597 0.03 0.02-0.04 2.70 2.51-
3.00 
591 13.1 12.8-
13.3 
19.8 19.5-
20.6 
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13 330 0.02 0.01-0.07 3.19 2.64-
3.54 
321 12.7 12.3-
13.1 
19.7 19.3-
21.2 
14 147 0.06 0.01-0.19 2.86 2.38-
3.49 
148 12.3 11.9-
13.0 
19.6 19.0-
21.1 
15-20 135 0.30 0.15-0.39 2.91 2.52-
3.27 
142 12.8 12.4-
13.4 
19.0 18.6-
20.7 
Live 
births  
          
4-6 87 0.62 0.59-0.67 3.72 3.29-
3.79 
85 13.2 12.7-
13.7 
20.1 19.3-
20.3 
7 182 0.44 0.36-0.61 3.00 2.73-
3.20 
186 12.3 12.1-
12.7 
20.8 19.3-
21.4 
8 624 0.35 0.29-0.43 3.19 2.99-
3.71 
626 12.7 12.3-
12.9 
19.7 19.5-
20.2 
9 2,504 0.14 0.11-0.17 2.88 2.76-
3.02 
2,485 13.1 13.0-
13.2 
20.6 20.3-
20.8 
10 3,255 0.11 0.09-0.13 2.70 2.60-
2.77 
3,303 13.1 12.9-
13.2 
20.7 20.4-
20.8 
11 1,600 0.12 0.09-0.14 2.83 2.70- 1,607 13.0 12.8- 20.3 20.0-
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Abbreviations: 2.5p: 2.5 percentile, 97.5p: 97.5 percentile, CI: confidence interval 
aNumber of individuals in each group is reported after the exclusion of outliers using Tukey’s fences.  
bLower reference limit was held at minimum of the sample in week 4-6, 14, and 15-20. 
cUpper reference limit was held at maximum of the sample in week 4-6, 14, and 15-20. 
  
2.97 13.1 20.8 
12 530 0.03 0.02-0.04 2.70 2.49-
3.00 
523 13.1 12.8-
13.4 
19.6 19.5-
20.4 
13 293 0.03 0.009-0.10 2.85 2.45-
3.50 
284 12.6 12.2-
12.9 
19.5 19.0-
20.4 
14 135 0.04 0.006-0.17 2.87 2.32-
3.49 
135 12.3 11.9-
13.0 
19.7 18.9-
21.1 
15-20 123 0.31 0.15-0.44 2.93 2.56-
3.27 
130 12.8 12.4-
13.4 
19.2 18.6-
20.7 
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Table 2 Reference limits of maternal TSH and free T4 with 95% confidence intervals in different periods of early pregnancy. 
 
 
 
 
 
 
 
 
Abbreviations: 2.5p: 2.5 percentile, 97.5p: 97.5 percentile, CI: confidence interval 
aNumber of individuals in each group is reported after the exclusion of outliers using Tukey’s fences.  
  
 Maternal TSH (mIU/l) Maternal free T4 (pmol/l)
Week na 2.5p 95% CI 97.5p 95% CI na 2.5p 95% CI 97.5p 95% CI 
All            
4-8 1,155 0.40 0.35-0.45 3.38 3.11-3.55 1,162 12.6 12.4-12.7 19.8 19.6-20.4
9-11 7,761 0.13 0.12-0.14 2.83 2.76-2.89 7,811 13.1 13.0-13.1 20.5 20.3-20.7 
12-14 1,072 0.03 0.02-0.05 2.77 2.63-3.01 1,057 12.9 12.7-13.1 19.7 19.5-20.3 
Live births      
4-8 898 0.39 0.35-0.46 3.40 3.11-3.61 898 12.6 12.3-12.8 19.8 19.6-20.3 
9-11 7,354 0.12 0.11-0.14 2.78 2.72-2.86 7,391 13.1 13.0-13.1 20.6 20.4-20.7 
12-14 958 0.03 0.02-0.05 2.71 2.58-3.00 945 12.7 12.5-13.0 19.6 19.5-20.0
D
ow
nl
oa
de
d 
by
 A
al
bo
rg
 U
ni
ve
rs
ite
ts
bi
bl
io
te
k 
fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
2/
13
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Page 24 of 29 
 
 
 
24 
Th
yr
oi
d 
cy
 w
ee
k 
sp
ec
ifi
c r
ef
er
en
ce
 ra
ng
es
 fo
r T
SH
 a
nd
 fr
ee
 T
4 
in
 th
e 
No
rt
h 
De
nm
ar
k 
Re
gi
on
 P
re
gn
an
cy
 C
oh
or
t  
(D
OI
: 1
0.
10
89
/t
hy
.2
01
8.
06
28
) 
re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 co
py
ed
iti
ng
 a
nd
 p
ro
of
 co
rr
ec
tio
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
Table 3 Characteristics of the 9,515 pregnant women who gave birth to a live-born singleton child.  
 
 
 n % 
Maternal age   
< 35 years 8,129 85.4 
≥ 35 years 1,386 14.6 
Maternal paritya   
Nulliparous 4,848 51.2
Multiparous 4,626 48.8 
Maternal origin   
Born in Denmark 8,403 88.3
Not born in Denmark 1,112 11.7 
Maternal smoking in pregnancyb   
No smoking  8,311 88.1
Smoking  1,121 11.9 
Maternal pre-pregnancy BMIc   
< 30  kg/m2 8,173 86.3
≥ 30 kg/m2 1,295 13.7 
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Abbreviations: BMI: body mass index 
aMissing value n = 41 not included. 
bMissing value n = 83 not included. 
cMissing value n = 47 not included. 
  
D
ow
nl
oa
de
d 
by
 A
al
bo
rg
 U
ni
ve
rs
ite
ts
bi
bl
io
te
k 
fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
2/
13
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Page 26 of 29 
 
 
 
26 
Th
yr
oi
d 
cy
 w
ee
k 
sp
ec
ifi
c r
ef
er
en
ce
 ra
ng
es
 fo
r T
SH
 a
nd
 fr
ee
 T
4 
in
 th
e 
No
rt
h 
De
nm
ar
k 
Re
gi
on
 P
re
gn
an
cy
 C
oh
or
t  
(D
OI
: 1
0.
10
89
/t
hy
.2
01
8.
06
28
) 
re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 co
py
ed
iti
ng
 a
nd
 p
ro
of
 co
rr
ec
tio
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
Table 4 Reference limits with 95% confidence intervals for maternal TSH and free T4 in pregnancy week 9-11 stratified by maternal 
characteristics. 
 
 
 Maternal TSH (mIU/l) Maternal free T4 (pmol/l) 
 na 2.5p 95% CI 97.5p 95% CI na 2.5p 95% CI 97.5p 95% CI
Maternal age           
< 35 years 6,191 0.13 0.11-0.14 2.79 2.72-2.87 6,223 13.1 13.0-13.2 20.6 20.4-20.7 
≥ 35 years 1,097 0.10 0.07-0.14 2.82 2.64-3.06 1,101 13.0 12.8-13.1 20.5 20.0-21.0 
Parity           
Nulliparous  3,702 0.15 0.13-0.17 2.86 2.78-2.94 3,734 13.1 12.9-13.1 20.5 20.2-20.7 
Multiparous 3,586 0.11 0.09-0.12 2.71 2.59-2.80 3,590 13.1 13.0-13.2 20.6 20.4-20.8 
Origin    
Born in Denmark  6,552 0.13 0.12-0.14 2.78 2.71-2.85 6,572 13.1 13.0-13.1 20.5 20.3-20.7 
Not born in Denmark 736 0.08 0.07-0.13 2.88 2.70-3.13 752 13.1 12.9-13.3 20.8 20.5-21.3 
Smoking in pregnancy           
No 6,483 0.13 0.11-0.14 2.82 2.73-2.88 6,517 13.1 13.0-13.2 20.6 20.4-20.7 
Yes 805 0.11 0.08-0.16 2.64 2.46-2.84 807 13.0 12.8-13.1 20.2 19.6-20.8 
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Abbreviations: 2.5p: 2.5 percentile, 97.5p: 97.5 percentile, CI: confidence interval, BMI: body mass index. 
aNumber of individuals in each group is reported after the exclusion of outliers using Tukey’s fences.  
 
 
  
Pre-pregnancy BMI            
< 30 kg/m2 6,320 0.12 0.11-0.13 2.74 2.69-2.83 6,357 13.1 13.1-13.2 20.6 20.4-20.8 
≥ 30 kg/m2 968 0.19 0.15-0.24 3.09 2.85-3.28 967 12.9 12.7-13.0 20.3 19.8-20.6 
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Legends to figures 
 
Figure 1 
Flowchart illustrating the selection of the reference cohort. 
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Figure 2 
Pregnancy week specific median with 95% confidence intervals for maternal TSH and free 
T4 in all 10,337 pregnant women from the North Denmark Region (figure 2a and 2b in the 
upper panel) and in the 9,515 pregnant women who gave birth to a live-born child (figure 
2c and 2d in the lower panel).  
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